查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722598

2025 年至 2033 年體外大腸直腸癌篩檢測試市場報告（按產品、影像類型、最終用戶和地區）

In-vitro Colorectal Cancer Screening Tests Market Report by Product, Imaging Type, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球體外大腸直腸癌篩檢測試市場規模達 10.492 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 16.587 億美元，2025-2033 年期間的成長率 (CAGR) 為 4.96%。

體外大腸直腸癌篩檢測試是用於檢測腺瘤、息肉和大腸直腸癌症狀的診斷程序。大腸直腸癌是指大腸、結腸和直腸細胞異常生長的疾病。糞便潛血 (FOB)、側流免疫、轉鐵蛋白測定、甲基化基因、生物標記和癒創木脂 FOB 糞便測試是一些常見的篩檢測試。體外大腸直腸癌篩檢測試涉及使用攝影機捕捉消化道影像並將其傳輸到綁在患者腰部的記錄儀上。它們具有微創性，可以幫助及時發現癌症。因此，體外大腸直腸癌篩檢測試在診所、醫院和診斷實驗室中廣泛進行。

體外大腸直腸癌篩檢測試市場趨勢：

人群中大腸癌盛行率的不斷上升是推動市場成長的關鍵因素之一。此外，人們對早期發現和及時治療癌症的好處的認知不斷提高，對市場成長產生了積極影響。各種技術進步，例如將基因檢測融入癌症篩檢測試，正在推動市場成長。這些測試有助於早期發現、制定治療計劃、防止癌細胞擴散並最大限度地降低相關疾病的風險。與此一致，人們越來越傾向於使用微創（MI）診斷程序來檢測結腸直腸癌，這有利於市場成長。其他因素，包括老年人口的增加（老年人更容易患上此類疾病）和醫療保健行業的重大改善，以及政府強制進行癌症篩檢測試的各種舉措的實施，預計將推動市場成長。

本報告回答的關鍵問題

  • 2024 年全球體外大腸直腸癌篩檢測試市場規模？ 2025 年至 2033 年期間全球體外大腸直腸癌篩檢測試市場的預期成長率為何？
  • COVID-19 對全球體外大腸直腸癌篩檢測試市場有何影響？
  • 推動全球體外大腸直腸癌篩檢測試市場發展的關鍵因素有哪些？
  • 根據產品，全球體外大腸直腸癌篩檢測試市場如何分佈？
  • 根據影像類型，全球體外大腸直腸癌篩檢測試市場如何分佈？
  • 根據最終用戶，全球體外大腸直腸癌篩檢測試市場是如何分佈的？
  • 全球體外大腸直腸癌篩檢測試市場的關鍵區域有哪些？
  • 全球體外大腸直腸癌篩檢測試市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球體外大腸直腸癌篩檢測試市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 糞便潛血檢測
    • 關鍵部分
      • 癒創木脂FOB糞便檢測
      • 免疫FOB凝集試驗
      • 側流免疫FOB測試
      • 免疫FOB ELISA測試
  • 生物標記測試
    • 關鍵部分
      • 腫瘤M2-PK糞便檢測
      • 轉鐵蛋白檢測
  • CRC DNA篩檢測試
    • 關鍵部分
      • 甲基化基因檢測
      • 小組 DNA 測試

第7章：市場區隔：依影像類型

  • 大腸鏡檢查
  • 直腸鏡檢查
  • CT掃描
  • 超音波
  • 磁振造影
  • 正子斷層掃描

第8章：市場區隔：按最終用戶

  • 醫院
  • 診所
  • 診斷實驗室
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Beckman Coulter Inc. (Danaher Corporation)
    • Eiken Chemical Co. Ltd.
    • Epigenomics AG
    • Exact Sciences Corporation
    • Hemosure Inc.
    • Immunostics Inc. (Boditech Med Inc.)
    • Medline Industries LP
    • Merck KGaA
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • R-Biopharm AG
    • Siemens AG
    • Sysmex Corporation
Product Code: SR112025A5383

The global in-vitro colorectal cancer screening tests market size reached USD 1,049.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,658.7 Million by 2033, exhibiting a growth rate (CAGR) of 4.96% during 2025-2033.

In-vitro colorectal cancer screening tests are diagnostic procedures performed to detect adenomas, polyps and symptoms of colorectal cancer. Colorectal cancer refers to a medical condition that is characterized by the abnormal growth of cells in the large intestine, colon and rectum. Fecal occult blood (FOB), lateral flow immuno, transferrin assays, methylated gene, biomarker and guaiac FOB stool test are some of the commonly performed screening tests. In-vitro colorectal cancer screening tests involve the use of cameras that capture images of the digestive tract and transfers them to the recorder tied to the waist of the patient. They are minimally invasive and can aid in timely detection of cancer. As a result, in-vitro colorectal cancer screening tests are widely performed across clinics, hospitals and diagnostics laboratories.

In-Vitro Colorectal Cancer Screening Tests Market Trends:

The increasing prevalence of colorectal cancer among the masses is one of the key factors driving the growth of the market. Moreover, rising awareness regarding the benefits of early detection and timely treatment of cancer is positively impacting the market growth. Various technological advancements, such as the integration of genetic testing in cancer screening tests, are providing a thrust to the market growth. These tests aid in early detection, developing treatment plans, preventing the spread of cancerous cells and minimizing the risks of developing associated disorders. In line with this, the increasing preference for minimally invasive (MI) diagnostic procedures to detect colorectal cancer is favoring the market growth. Other factors, including rising geriatric populations, which is more susceptible to such ailments and significant improvements in the healthcare industry, along with the implementation of various government initiatives mandating cancer screening tests, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Product:

  • Fecal Occult Blood Tests
  • Guaiac FOB Stool Test
  • Immuno-FOB Agglutination Test
  • Lateral Flow Immuno-FOB Test
  • Immuno-FOB ELISA Test
  • Biomarker Tests
  • Tumor M2-PK Stool Test
  • Transferrin Assays
  • CRC DNA Screening Tests
  • Methylated Gene Testing
  • Panel DNA Tests

Breakup by Imaging Type:

  • Colonoscopy
  • Proctoscopy
  • CT Scan
  • Ultrasound
  • MRI
  • PET Scan

Breakup by End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Beckman Coulter Inc. (Danaher Corporation), Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corporation, Hemosure Inc., Immunostics Inc. (Boditech Med Inc.), Medline Industries LP, Merck KGaA, Qiagen N.V., Quest Diagnostics Incorporated, R-Biopharm AG, Siemens AG and Sysmex Corporation.

Key Questions Answered in This Report

  • 1.What was the size of the global in-vitro colorectal cancer screening tests market in 2024?
  • 2.What is the expected growth rate of the global in-vitro colorectal cancer screening tests market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global in-vitro colorectal cancer screening tests market?
  • 4.What are the key factors driving the global in-vitro colorectal cancer screening tests market?
  • 5.What is the breakup of the global in-vitro colorectal cancer screening tests market based on the product?
  • 6.What is the breakup of the global in-vitro colorectal cancer screening tests market based on the imaging type?
  • 7.What is the breakup of the global in-vitro colorectal cancer screening tests market based on end user?
  • 8.What are the key regions in the global in-vitro colorectal cancer screening tests market?
  • 9.Who are the key players/companies in the global in-vitro colorectal cancer screening tests market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global In-vitro Colorectal Cancer Screening Tests Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Fecal Occult Blood Tests
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Guaiac FOB Stool Test
      • 6.1.2.2 Immuno-FOB Agglutination Test
      • 6.1.2.3 Lateral Flow Immuno-FOB Test
      • 6.1.2.4 Immuno-FOB ELISA Test
    • 6.1.3 Market Forecast
  • 6.2 Biomarker Tests
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Tumor M2-PK Stool Test
      • 6.2.2.2 Transferrin Assays
    • 6.2.3 Market Forecast
  • 6.3 CRC DNA Screening Tests
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Methylated Gene Testing
      • 6.3.2.2 Panel DNA Tests
    • 6.3.3 Market Forecast

7 Market Breakup by Imaging Type

  • 7.1 Colonoscopy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Proctoscopy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 CT Scan
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Ultrasound
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 MRI
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 PET Scan
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Eiken Chemical Co. Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Epigenomics AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Exact Sciences Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Hemosure Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Immunostics Inc. (Boditech Med Inc.)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Medline Industries LP
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Qiagen N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Quest Diagnostics Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 R-Biopharm AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Siemens AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Sysmex Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: In-vitro Colorectal Cancer Screening Tests Market: Major Drivers and Challenges
  • Figure 2: Global: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Product (in %), 2024
  • Figure 5: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Imaging Type (in %), 2024
  • Figure 6: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by End User (in %), 2024
  • Figure 7: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Region (in %), 2024
  • Figure 8: Global: In-vitro Colorectal Cancer Screening Tests (Fecal Occult Blood Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: In-vitro Colorectal Cancer Screening Tests (Fecal Occult Blood Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: In-vitro Colorectal Cancer Screening Tests (Biomarker Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: In-vitro Colorectal Cancer Screening Tests (Biomarker Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: In-vitro Colorectal Cancer Screening Tests (CRC DNA Screening Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: In-vitro Colorectal Cancer Screening Tests (CRC DNA Screening Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: In-vitro Colorectal Cancer Screening Tests (Colonoscopy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: In-vitro Colorectal Cancer Screening Tests (Colonoscopy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: In-vitro Colorectal Cancer Screening Tests (Proctoscopy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: In-vitro Colorectal Cancer Screening Tests (Proctoscopy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: In-vitro Colorectal Cancer Screening Tests (CT Scan) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: In-vitro Colorectal Cancer Screening Tests (CT Scan) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: In-vitro Colorectal Cancer Screening Tests (Ultrasound) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: In-vitro Colorectal Cancer Screening Tests (Ultrasound) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: In-vitro Colorectal Cancer Screening Tests (MRI) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: In-vitro Colorectal Cancer Screening Tests (MRI) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: In-vitro Colorectal Cancer Screening Tests (PET Scan) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: In-vitro Colorectal Cancer Screening Tests (PET Scan) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: In-vitro Colorectal Cancer Screening Tests (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: In-vitro Colorectal Cancer Screening Tests (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: In-vitro Colorectal Cancer Screening Tests (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: In-vitro Colorectal Cancer Screening Tests (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: In-vitro Colorectal Cancer Screening Tests (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: In-vitro Colorectal Cancer Screening Tests (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: In-vitro Colorectal Cancer Screening Tests (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: In-vitro Colorectal Cancer Screening Tests (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia-Pacific: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: In-vitro Colorectal Cancer Screening Tests Industry: SWOT Analysis
  • Figure 84: Global: In-vitro Colorectal Cancer Screening Tests Industry: Value Chain Analysis
  • Figure 85: Global: In-vitro Colorectal Cancer Screening Tests Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: In-vitro Colorectal Cancer Screening Tests Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Imaging Type (in Million USD), 2025-2033
  • Table 4: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: In-vitro Colorectal Cancer Screening Tests Market: Competitive Structure
  • Table 7: Global: In-vitro Colorectal Cancer Screening Tests Market: Key Players